CHORDOMA AND ALVEOLAR SOFT PART SARCOMA

Clinical trials for CHORDOMA AND ALVEOLAR SOFT PART SARCOMA explained in plain language.

Never miss a new study

Get alerted when new CHORDOMA AND ALVEOLAR SOFT PART SARCOMA trials appear

Sign up with your email to follow new studies for CHORDOMA AND ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New drug trial aims to rev up immune system to fight advanced cancers

Disease control Terminated

This was a first-in-human study to test the safety and find the right dose of a new immunotherapy drug called FAZ053. It was given alone and in combination with another drug, PDR001, to 154 adults with advanced solid tumors that had stopped responding to standard treatments. The …

Matched conditions: CHORDOMA AND ALVEOLAR SOFT PART SARCOMA

Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

CHORDOMA AND ALVEOLAR SOFT PART SARCOMA

Get alerted when new CHORDOMA AND ALVEOLAR SOFT PART SARCOMA trials appear

New drug trial aims to rev up immune system to fight advanced cancers